As of 2025-05-14, the EV/EBITDA ratio of Infinity Pharmaceuticals Inc (INFI) is 0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INFI's latest enterprise value is -16.29 mil USD. INFI's TTM EBITDA according to its financial statements is -41.62 mil USD. Dividing these 2 quantities gives us the above INFI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 13.5x | 13.4x |
| Forward P/E multiples | 18.9x - 27.1x | 23.0x |
| Fair Price | (23.67) - (16.75) | (22.80) |
| Upside | -53043.5% - -37567.7% | -51109.0% |
| Date | EV/EBITDA |